Information on the safety of medicines
This page contains a list of changes made to the instructions for medical use
№
Date
Document description
View document
884/04-23
07/04/2021
New Risk of Regurgitation development / heart valve failure associated with fluoroquinolones for systemic and inhalation use.
529/03-23
12/03/2019
On amendments to the instruction leaflet for medical use of the medicinal product Gabapentin 300 mg hard capsules, 10 capsules in a blister, 2 blisters in a carton, the applicant/manufacturer: PJSC «Technolog».
419/02-23
21/02/2019
On amendments to the instruction leaflet for medical use of the medicinal product Ciprofloxacin 250 mg tablets, 10 tablets in a blister or 900 tablets in blisters in a box; 500 mg tablets in a blister, 10 tablets in a carton or 700 tablets in a blister in a box; Levofloxacin (ЛЕВОФЛОКСАЦИН) 250 and 500 mg tablets, 10 tablets in a blister, 1 blister in a carton, the applicant/manufacturer: PJSC «Technolog».
